Hi synaphai. Realise it's an estimate, but what is the basis for your $400m? Is it just what you've seen before and you're applying same here?
For Anteris, there's the big trial to come but my understanding is we are paid for that (to cover costs, not full commercial pricing). Beyond that, the commercial rollout has been positioned by Wayne to be funded through sales margins and outsourcing manufacture. I think a fairly large initial capital chunk would be needed to kickstart production, but as many have noted we have a lot of options with the dates of expiry coinciding pretty well with the likely rollout timetable. So yes, agree, money will come from issued shares, but not necessarily result in more dilution than we already have with existing unlisted options.
Cheers.
AVR Price at posting:
$19.26 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)